European markets see sharp losses after disappointing eurozone data, but some local stocks push higher anyway
Possibilists allow data and possibilities to emerge and enlighten us — and the data and possibilities we possess on this continent are potentially quite astounding
ANC head of elections Fikile Mbalula gave testimony before the Zondo inquiry into state capture on Friday‚ speaking on the looting of state resources and his relationship with the controversial Gupta ...
Political analyst Daniel Silke talks to Business Day TV about the high number of parties contesting the 2019 elections
Dream team for Vedanta as Chris Sheppard joins former AngloGold Ashanti boss to head the Zambian copper business.
Goldman Sachs says load-shedding could subtract 0.3 percentage points of economic growth in the first quarter
Economic development minister Ebrahim Patel says his department wants to make sure that the Competition Commission and Competition Tribunal are efficient to ensure that they are ready to implement ...
Attorney general William Barr said he may be able to provide lawmakers with the special counsel’s principal conclusions “as soon as this weekend”
SA’s ambassador to the UN welcomed the council’s resolution, saying that barring Caster Semenya is like excluding a child from class for having a high IQ
No vintage is the same so success is never absolute, but rather a reflection of the best possible
Healthcare company 'has no option' but to sell Cyprus-based pharmaceutical maker Remedica to help pay off R3.7bn in offshore debts
The company has ascribed an increase in financial gearing to the weaker rand and increased short-term debt facilities
Lack of growth in the medical schemes market has resulted in the group exploring ways to provide more services to patients paying out of their own pockets
Global pharmaceutical company stocks hit worst level in nine years
Investors are concerned that the company’s borrowings, net of cash, have increased
Aspen shareholders are in for an anticipated disappointment after Africa's largest pharmaceutical company's earnings grew by a mere 1% in the half year to ...
While it will continue selling its brand-name version at the existing price, Lilly will also sell a half-cost ‘authorised generic’
Discovery CEO Adrian Gore talks to Business Day TV about the group’s interim results and its costly new initiatives
CEO Andy Hall says the company will not go into tenders that do not pay because, as a listed company, it cannot afford to do unprofitable business
SA’s two biggest pharmaceutical manufacturers awarded a quarter of the government’s R18.3bn drug tender
The pharmaceuticals group said its investment in local manufacturing facilities has paid off
Auris has developed robotic surgical scopes operated with a handheld device that is steered into patients’ lungs to identify cancerous tumours
Sanofi and Regeneron cut list price by 60% to give US consumers better access and to lower out-of-pocket costs
The company has now earmarked its bio-science division for an additional sale
The tribunal says a proposed merger with Matlosana Medical Health Services would substantially lessen competition in the province
The share has climbed from recent lows, partly on optimism that the forced sales of stock were slowing
The settlement ends a long-standing dispute over medical devices
SA’s biggest private hospital group presented its final argument to the Competition Tribunal
Business Life Healthcare CEO Shrey Viranna joins Business Day TV to discuss the company’s deal with Radiant Life
News of the sale lifted the health company’s share price which plummeted in 2018 amid concerns about its indebtedness
Published by Tiso Blackstar and distributed
with the Financial Mail on the last Thursday
of every month except December and January.